Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale
Top Cited Papers
- 4 June 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (22) , 2625-2631
- https://doi.org/10.1161/01.cir.0000017498.88393.44
Abstract
Background— Patent foramen ovale (PFO) is associated with stroke, but there are no randomized studies to evaluate the efficacy of antithrombotic therapies.Keywords
This publication has 21 references indexed in Scilit:
- Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or BothNew England Journal of Medicine, 2001
- A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic StrokeNew England Journal of Medicine, 2001
- Paradoxical Embolism — Thrombus in Transit through a Patent Foramen OvaleNew England Journal of Medicine, 1997
- The Feasibility of a Collaborative Double-Blind Study Using an AnticoagulantCerebrovascular Diseases, 1997
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Glasgow Outcome Scale: An inter-rater reliability studyBrain Injury, 1993
- Infarcts of undetermined cause: The NINCDS stroke data bankAnnals of Neurology, 1989
- PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTSThe Lancet, 1988
- Prevalence of Patent Foramen Ovale in Patients with StrokeNew England Journal of Medicine, 1988
- Incidence and Size of Patent Foramen Ovale During the First 10 Decades of Life: An Autopsy Study of 965 Normal HeartsPublished by Elsevier ,1984